SCHEMBL29937346

SCHEMBL29937346

CSc1ncc2ccccc2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
LMNA P02545 2/20 0.44
HTT P42858 2/20 0.44
PCSK9 Q8NBP7 1/20 0.44
CYP1A2 P05177 4/20 0.43
ALDH1A1 P00352 5/20 0.43
MAPT P10636 4/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
HTR3A P46098 1/20 0.42
HRH4 Q9H3N8 1/20 0.42
GPR3 P46089 1/20 0.42
EGFR P00533 1/20 0.42
HPGD P15428 2/20 0.41
NTRK1 P04629 1/20 0.41
GLA P06280 1/20 0.39
ACHE P22303 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL159102 1.00 KDM4E (0.44) KDM4ESMN1; SMN2LMNAHTTPCSK9
SCHEMBL15659227 0.83 KDM4E (0.45) KDM4EPCSK9CYP1A2ALDH1A1MAPT
SCHEMBL15659229 0.79 KDM4E (0.42) KDM4EPCSK9CYP1A2ALDH1A1MAPT
SCHEMBL15565731 0.76 HASPIN (0.53) KDM4EHTTALDH1A1NTRK1MEN1
SCHEMBL30443506 0.76 HASPIN (0.49) KDM4ESMN1; SMN2HTTALDH1A1NTRK1
SCHEMBL17049278 0.76 RPS6KA5 (0.48) KDM4ESMN1; SMN2LMNAHTTALDH1A1
SCHEMBL30904526 0.75 KDM4E (0.38) KDM4EPCSK9CYP1A2ALDH1A1MAPT
SCHEMBL28036135 0.74 HAO1 (0.41) KDM4ESMN1; SMN2HTTCYP1A2ALDH1A1
SCHEMBL17652985 0.73 ALDH1A1 (0.44) KDM4ELMNAHTTCYP1A2ALDH1A1
SCHEMBL1571542 0.73 ESR2 (0.42) KDM4ESMN1; SMN2ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747239-A1 SMALL MOLECULE PROTEIN DEGRADERS OF KRAS G12D MUTANT Merck Sharp & Dohme LLC (US) 2026-05-27 EP disclosed
WO-2025019823-A1 SMALL MOLECULE PROTEIN DEGRADERS OF KRAS G12D MUTANT MERCK SHARP & DOHME LLC (US) 2025-01-23 WO disclosed
CN-117836286-A Heterocyclic EGFR inhibitors for the treatment of cancer 缆图药品公司 2024-04-05 CN disclosed
EP-4322954-A1 SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT Merck Sharp & Dohme LLC (US) 2024-02-21 EP disclosed
WO-2023244713-A1 QUINAZOLINE DERIVATIVES, COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2023-12-21 WO disclosed
EP-4125845-A1 NOVEL 2-PYRIMIDONE ANALOGS AS POTENT ANTIVIRAL AGENTS AGAINST ALPHAVIRUSES Southern Research Institute (US) 2023-02-08 EP disclosed
WO-2022221739-A1 SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT MERCK SHARP & DOHME CORP. (US) 2022-10-20 WO disclosed